Statin myopathies: pathophysiologic and clinical perspectives

Clin Invest Med. 2001 Oct;24(5):258-72.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticholesteremic Agents / adverse effects*
  • Drug Interactions
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Muscular Diseases / chemically induced*

Substances

  • Anticholesteremic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors